Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative KPTI - Karyopharm Therapeutics Inc.
115 M
LAST VALUE
-10.90%
2 YEAR CAGR
1.83%
5 YEAR CAGR
21.89%
10 YEAR CAGR